Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	json	split
Roles of cell adhesion molecules mediating the interaction of cancer and endothelial cells in tumor angiogenesis were investigated using new in vitro and in vivo model systems with a cultured murine endothelial cell line ( F - 2) and human cultured epidermoid cancer cells ( A431).	cell,9,13,Cell	cancer,62,68,Cell	endothelial cells,73,90,Cell	tumor,94,99,Cancer	murine,192,198,Organism	endothelial cell line,199,220,Cell	F - 2,223,228,Cell	human,234,239,Organism	epidermoid cancer cells,249,272,Cell	A431,275,279,Cell	"[{""token"": ""cell"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""cancer"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""endothelial cells"", ""start_span"": 73, ""end_span"": 90, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Cancer""}, {""token"": ""murine"", ""start_span"": 192, ""end_span"": 198, ""type"": ""Organism""}, {""token"": ""endothelial cell line"", ""start_span"": 199, ""end_span"": 220, ""type"": ""Cell""}, {""token"": ""F - 2"", ""start_span"": 223, ""end_span"": 228, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 234, ""end_span"": 239, ""type"": ""Organism""}, {""token"": ""epidermoid cancer cells"", ""start_span"": 249, ""end_span"": 272, ""type"": ""Cell""}, {""token"": ""A431"", ""start_span"": 275, ""end_span"": 279, ""type"": ""Cell""}]"	train
Using immunoblot analysis, we show that AdGFPFasL ( TET) is capable of initiating the classic Fas - mediated apoptotic pathway in DU145 cells, which includes activation of caspases - 8, - 3, - 7, and - 9, BID cleavage, cytochrome c release from mitochondria, and PARP cleavage.	Fas,45,48,Gene_or_gene_product	DU145 cells,130,141,Cell	caspases - 8,172,184,Gene_or_gene_product	- 3,186,189,Gene_or_gene_product	- 7,191,194,Gene_or_gene_product	- 9,200,203,Gene_or_gene_product	BID,205,208,Gene_or_gene_product	cytochrome c,219,231,Gene_or_gene_product	mitochondria,245,257,Cellular_component	PARP,263,267,Gene_or_gene_product	"[{""token"": ""Fas"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""DU145 cells"", ""start_span"": 130, ""end_span"": 141, ""type"": ""Cell""}, {""token"": ""caspases - 8"", ""start_span"": 172, ""end_span"": 184, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 3"", ""start_span"": 186, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 7"", ""start_span"": 191, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""- 9"", ""start_span"": 200, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""BID"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytochrome c"", ""start_span"": 219, ""end_span"": 231, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitochondria"", ""start_span"": 245, ""end_span"": 257, ""type"": ""Cellular_component""}, {""token"": ""PARP"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Gene_or_gene_product""}]"	train
By means of intravital microscopy, tumor necrosis factor alpha - stimulated leukocyte - vessel wall interactions were studied in ear skin microvessels of nude mice bearing small human LS174T colon carcinomas and in C57Bl / 6 mice bearing murine B16F10 melanomas.	tumor necrosis factor alpha,35,62,Gene_or_gene_product	leukocyte,76,85,Cell	vessel wall,88,99,Multi	ear skin microvessels,129,150,Tissue	nude mice,154,163,Organism	human,178,183,Organism	LS174T colon carcinomas,184,207,Cancer	C57Bl / 6 mice,215,229,Organism	murine,238,244,Organism	B16F10 melanomas,245,261,Cancer	"[{""token"": ""tumor necrosis factor alpha"", ""start_span"": 35, ""end_span"": 62, ""type"": ""Gene_or_gene_product""}, {""token"": ""leukocyte"", ""start_span"": 76, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""vessel wall"", ""start_span"": 88, ""end_span"": 99, ""type"": ""Multi""}, {""token"": ""ear skin microvessels"", ""start_span"": 129, ""end_span"": 150, ""type"": ""Tissue""}, {""token"": ""nude mice"", ""start_span"": 154, ""end_span"": 163, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 178, ""end_span"": 183, ""type"": ""Organism""}, {""token"": ""LS174T colon carcinomas"", ""start_span"": 184, ""end_span"": 207, ""type"": ""Cancer""}, {""token"": ""C57Bl / 6 mice"", ""start_span"": 215, ""end_span"": 229, ""type"": ""Organism""}, {""token"": ""murine"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Organism""}, {""token"": ""B16F10 melanomas"", ""start_span"": 245, ""end_span"": 261, ""type"": ""Cancer""}]"	train
Experimental Design: Human umbilical vein and dermal microvascular endothelial cells were infected with replication - deficient adenoviruses encoding survivin ( pAd - Survivin), green fluorescent protein ( pAd - GFP), or a phosphorylation - defective survivin Thr ( 34) - - > Ala ( pAd - T34A) dominant negative mutant.	Human,21,26,Organism	umbilical vein,27,41,Cell	dermal microvascular endothelial cells,46,84,Cell	adenoviruses,128,140,Organism	survivin,150,158,Gene_or_gene_product	pAd - Survivin,161,175,Gene_or_gene_product	green fluorescent protein,178,203,Gene_or_gene_product	pAd - GFP,206,215,Gene_or_gene_product	survivin,251,259,Gene_or_gene_product	pAd - T34A,282,292,Gene_or_gene_product	"[{""token"": ""Human"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Organism""}, {""token"": ""umbilical vein"", ""start_span"": 27, ""end_span"": 41, ""type"": ""Cell""}, {""token"": ""dermal microvascular endothelial cells"", ""start_span"": 46, ""end_span"": 84, ""type"": ""Cell""}, {""token"": ""adenoviruses"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Organism""}, {""token"": ""survivin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - Survivin"", ""start_span"": 161, ""end_span"": 175, ""type"": ""Gene_or_gene_product""}, {""token"": ""green fluorescent protein"", ""start_span"": 178, ""end_span"": 203, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - GFP"", ""start_span"": 206, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Gene_or_gene_product""}, {""token"": ""pAd - T34A"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Gene_or_gene_product""}]"	train
To investigate this possibility, we studied the influence of bovine lactoferrin on Fas - mediated apoptosis with regard to expression of Fas, activation of caspase - 8 and caspase - 3, and DNA fragmentation in the colon mucosa of AOM - treated rats.	bovine,61,67,Organism	lactoferrin,68,79,Gene_or_gene_product	Fas,83,86,Gene_or_gene_product	Fas,137,140,Gene_or_gene_product	caspase - 8,156,167,Gene_or_gene_product	caspase - 3,172,183,Gene_or_gene_product	DNA,189,192,Cellular_component	colon mucosa,214,226,Multi	AOM,230,233,Chemical	rats,244,248,Organism	"[{""token"": ""bovine"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""lactoferrin"", ""start_span"": 68, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""Fas"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 8"", ""start_span"": 156, ""end_span"": 167, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase - 3"", ""start_span"": 172, ""end_span"": 183, ""type"": ""Gene_or_gene_product""}, {""token"": ""DNA"", ""start_span"": 189, ""end_span"": 192, ""type"": ""Cellular_component""}, {""token"": ""colon mucosa"", ""start_span"": 214, ""end_span"": 226, ""type"": ""Multi""}, {""token"": ""AOM"", ""start_span"": 230, ""end_span"": 233, ""type"": ""Chemical""}, {""token"": ""rats"", ""start_span"": 244, ""end_span"": 248, ""type"": ""Organism""}]"	train
To test the hypothesis that 20 - HETE increases endothelial cell ( EC) proliferation via vascular endothelial growth factor ( VEGF), we studied the effects of WIT003 [ 20 - hydroxyeicosa - 5 ( Z), 14 ( Z) - dienoic acid], a 20 - HETE analog on human macrovascular or microvascular EC.	20 - HETE,28,37,Chemical	endothelial cell,48,64,Cell	EC,67,69,Cell	vascular endothelial growth factor,89,123,Gene_or_gene_product	VEGF,126,130,Gene_or_gene_product	WIT003,159,165,Chemical	20 - HETE,224,233,Chemical	human,244,249,Organism	macrovascular,250,263,Cell	microvascular EC,267,283,Cell	"[{""token"": ""20 - HETE"", ""start_span"": 28, ""end_span"": 37, ""type"": ""Chemical""}, {""token"": ""endothelial cell"", ""start_span"": 48, ""end_span"": 64, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 67, ""end_span"": 69, ""type"": ""Cell""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 89, ""end_span"": 123, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 126, ""end_span"": 130, ""type"": ""Gene_or_gene_product""}, {""token"": ""WIT003"", ""start_span"": 159, ""end_span"": 165, ""type"": ""Chemical""}, {""token"": ""20 - HETE"", ""start_span"": 224, ""end_span"": 233, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 244, ""end_span"": 249, ""type"": ""Organism""}, {""token"": ""macrovascular"", ""start_span"": 250, ""end_span"": 263, ""type"": ""Cell""}, {""token"": ""microvascular EC"", ""start_span"": 267, ""end_span"": 283, ""type"": ""Cell""}]"	train
Papilloma formation was observed in both the DMBA - TPA - and DMBA - Cum - OOH - exposed animals, whereas skin carcinomas were found only in the DMBA - Cum - OOH - treated mice.	Papilloma,0,9,Pathological_formation	DMBA,45,49,Chemical	TPA,52,55,Chemical	DMBA,62,66,Chemical	Cum - OOH,69,78,Chemical	animals,89,96,Organism	skin carcinomas,106,121,Cancer	DMBA,145,149,Chemical	Cum - OOH,152,161,Chemical	mice,172,176,Organism	"[{""token"": ""Papilloma"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Pathological_formation""}, {""token"": ""DMBA"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""TPA"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical""}, {""token"": ""DMBA"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 69, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""animals"", ""start_span"": 89, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""skin carcinomas"", ""start_span"": 106, ""end_span"": 121, ""type"": ""Cancer""}, {""token"": ""DMBA"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Chemical""}, {""token"": ""Cum - OOH"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical""}, {""token"": ""mice"", ""start_span"": 172, ""end_span"": 176, ""type"": ""Organism""}]"	train
Vascular endothelial growth factor ( VEGF) and Angiopoietin 1 ( Ang1) are both potent proangiogenic factors, but, whereas VEGF causes vascular permeability, Ang1 stabilizes blood vessels and protects them from VEGF - induced plasma leakage.	Vascular endothelial growth factor,0,34,Gene_or_gene_product	VEGF,37,41,Gene_or_gene_product	Angiopoietin 1,47,61,Gene_or_gene_product	Ang1,64,68,Gene_or_gene_product	VEGF,122,126,Gene_or_gene_product	vascular,134,142,Multi	Ang1,157,161,Gene_or_gene_product	blood vessels,173,186,Multi	VEGF,210,214,Gene_or_gene_product	plasma,225,231,Organism_substance	"[{""token"": ""Vascular endothelial growth factor"", ""start_span"": 0, ""end_span"": 34, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""Angiopoietin 1"", ""start_span"": 47, ""end_span"": 61, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ang1"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 122, ""end_span"": 126, ""type"": ""Gene_or_gene_product""}, {""token"": ""vascular"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Multi""}, {""token"": ""Ang1"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene_or_gene_product""}, {""token"": ""blood vessels"", ""start_span"": 173, ""end_span"": 186, ""type"": ""Multi""}, {""token"": ""VEGF"", ""start_span"": 210, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""plasma"", ""start_span"": 225, ""end_span"": 231, ""type"": ""Organism_substance""}]"	train
Immunohistochemical studies showed that the epithelioid cells were strongly positive for a broad spectrum of cytokeratins ( AE1 / AE3, CAM5. 2, epithelial membrane antigen and cytokeratin 7) and mesothelial markers ( calretinin, Wilms ' tumour 1 and D2 - 40).	epithelioid cells,44,61,Cell	cytokeratins,109,121,Gene_or_gene_product	AE1,124,127,Gene_or_gene_product	AE3,130,133,Gene_or_gene_product	epithelial membrane antigen,144,171,Gene_or_gene_product	cytokeratin 7,176,189,Gene_or_gene_product	mesothelial,195,206,Tissue	calretinin,217,227,Gene_or_gene_product	Wilms ' tumour 1,229,245,Gene_or_gene_product	D2 - 40,250,257,Gene_or_gene_product	"[{""token"": ""epithelioid cells"", ""start_span"": 44, ""end_span"": 61, ""type"": ""Cell""}, {""token"": ""cytokeratins"", ""start_span"": 109, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""AE1"", ""start_span"": 124, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""AE3"", ""start_span"": 130, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial membrane antigen"", ""start_span"": 144, ""end_span"": 171, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytokeratin 7"", ""start_span"": 176, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""mesothelial"", ""start_span"": 195, ""end_span"": 206, ""type"": ""Tissue""}, {""token"": ""calretinin"", ""start_span"": 217, ""end_span"": 227, ""type"": ""Gene_or_gene_product""}, {""token"": ""Wilms ' tumour 1"", ""start_span"": 229, ""end_span"": 245, ""type"": ""Gene_or_gene_product""}, {""token"": ""D2 - 40"", ""start_span"": 250, ""end_span"": 257, ""type"": ""Gene_or_gene_product""}]"	train
The purpose of this study was to examine the effect of tricyclic antidepressant desipramine ( DMI) on the growth inhibition and translocation of the glucocorticoid receptor ( GR) from the cytoplasm to the nucleus in cancerous and noncancerous cell lines and the effect of DMI on GR - mediated transcription.	desipramine,80,91,Chemical	DMI,94,97,Chemical	glucocorticoid receptor,149,172,Gene_or_gene_product	GR,175,177,Gene_or_gene_product	cytoplasm,188,197,Organism_substance	nucleus,205,212,Cellular_component	cancerous,216,225,Cell	noncancerous cell lines,230,253,Cell	DMI,272,275,Chemical	GR,279,281,Gene_or_gene_product	"[{""token"": ""desipramine"", ""start_span"": 80, ""end_span"": 91, ""type"": ""Chemical""}, {""token"": ""DMI"", ""start_span"": 94, ""end_span"": 97, ""type"": ""Chemical""}, {""token"": ""glucocorticoid receptor"", ""start_span"": 149, ""end_span"": 172, ""type"": ""Gene_or_gene_product""}, {""token"": ""GR"", ""start_span"": 175, ""end_span"": 177, ""type"": ""Gene_or_gene_product""}, {""token"": ""cytoplasm"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Organism_substance""}, {""token"": ""nucleus"", ""start_span"": 205, ""end_span"": 212, ""type"": ""Cellular_component""}, {""token"": ""cancerous"", ""start_span"": 216, ""end_span"": 225, ""type"": ""Cell""}, {""token"": ""noncancerous cell lines"", ""start_span"": 230, ""end_span"": 253, ""type"": ""Cell""}, {""token"": ""DMI"", ""start_span"": 272, ""end_span"": 275, ""type"": ""Chemical""}, {""token"": ""GR"", ""start_span"": 279, ""end_span"": 281, ""type"": ""Gene_or_gene_product""}]"	train
Glutathione supplementation reversed the inhibitory effects of EPOX on ERK, which increases the phosphorylation of Mcl - 1 at T ( 163.) Overexpression of mitogen - activated protein / ERK kinase ( MEK) partially reversed the effect of EPOX on Mcl - 1 dephosphorylation, ubiquitination, and degradation, further implicating ERK in the regulation of Mcl - 1 stability.	Glutathione,0,11,Chemical	EPOX,63,67,Chemical	ERK,71,74,Gene_or_gene_product	Mcl - 1,115,122,Gene_or_gene_product	mitogen - activated protein / ERK kinase,154,194,Gene_or_gene_product	MEK,197,200,Gene_or_gene_product	EPOX,235,239,Chemical	Mcl - 1,243,250,Gene_or_gene_product	ERK,323,326,Gene_or_gene_product	Mcl - 1,348,355,Gene_or_gene_product	"[{""token"": ""Glutathione"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical""}, {""token"": ""EPOX"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Chemical""}, {""token"": ""ERK"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mcl - 1"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""mitogen - activated protein / ERK kinase"", ""start_span"": 154, ""end_span"": 194, ""type"": ""Gene_or_gene_product""}, {""token"": ""MEK"", ""start_span"": 197, ""end_span"": 200, ""type"": ""Gene_or_gene_product""}, {""token"": ""EPOX"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Chemical""}, {""token"": ""Mcl - 1"", ""start_span"": 243, ""end_span"": 250, ""type"": ""Gene_or_gene_product""}, {""token"": ""ERK"", ""start_span"": 323, ""end_span"": 326, ""type"": ""Gene_or_gene_product""}, {""token"": ""Mcl - 1"", ""start_span"": 348, ""end_span"": 355, ""type"": ""Gene_or_gene_product""}]"	train
HT - 29 human colorectal cancer xenograft model was used and tumour growth, microvessel density and VEGF quantification were performed in tumours after the administration of metronomic CPT - 11, L - OHP, 5 - FU and their simultaneous combination.	HT - 29,0,7,Cell	human,8,13,Organism	colorectal cancer xenograft,14,41,Cancer	tumour,61,67,Cancer	microvessel,76,87,Tissue	VEGF,100,104,Gene_or_gene_product	tumours,138,145,Cancer	CPT - 11,185,193,Chemical	L - OHP,195,202,Chemical	5 - FU,204,210,Chemical	"[{""token"": ""HT - 29"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 8, ""end_span"": 13, ""type"": ""Organism""}, {""token"": ""colorectal cancer xenograft"", ""start_span"": 14, ""end_span"": 41, ""type"": ""Cancer""}, {""token"": ""tumour"", ""start_span"": 61, ""end_span"": 67, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 76, ""end_span"": 87, ""type"": ""Tissue""}, {""token"": ""VEGF"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 138, ""end_span"": 145, ""type"": ""Cancer""}, {""token"": ""CPT - 11"", ""start_span"": 185, ""end_span"": 193, ""type"": ""Chemical""}, {""token"": ""L - OHP"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Chemical""}, {""token"": ""5 - FU"", ""start_span"": 204, ""end_span"": 210, ""type"": ""Chemical""}]"	train
Systemic inhibitors of TNF such as etanercept ( Enbrel) ( a soluble TNF receptor) and infliximab ( Remicade) and adalimumab ( Humira) ( anti - TNF antibodies) have been approved for the treatment inflammatory bowel disease, psoriasis and rheumatoid arthritis.	TNF,23,26,Gene_or_gene_product	etanercept,35,45,Chemical	Enbrel,48,54,Chemical	TNF,68,71,Gene_or_gene_product	infliximab,86,96,Chemical	Remicade,99,107,Chemical	adalimumab,113,123,Chemical	Humira,126,132,Chemical	anti - TNF antibodies,136,157,Gene_or_gene_product	bowel,209,214,Organ	"[{""token"": ""TNF"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Gene_or_gene_product""}, {""token"": ""etanercept"", ""start_span"": 35, ""end_span"": 45, ""type"": ""Chemical""}, {""token"": ""Enbrel"", ""start_span"": 48, ""end_span"": 54, ""type"": ""Chemical""}, {""token"": ""TNF"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""infliximab"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical""}, {""token"": ""Remicade"", ""start_span"": 99, ""end_span"": 107, ""type"": ""Chemical""}, {""token"": ""adalimumab"", ""start_span"": 113, ""end_span"": 123, ""type"": ""Chemical""}, {""token"": ""Humira"", ""start_span"": 126, ""end_span"": 132, ""type"": ""Chemical""}, {""token"": ""anti - TNF antibodies"", ""start_span"": 136, ""end_span"": 157, ""type"": ""Gene_or_gene_product""}, {""token"": ""bowel"", ""start_span"": 209, ""end_span"": 214, ""type"": ""Organ""}]"	train
Chicken embryo fibroblasts and hamster BHK cells transformed by Rous sarcoma virus ( RSV) release in their culture media growth factors which enhance markedly anchorage - independent colony formation in gelified medium, at the restrictive temperature ( 41 degrees 5 C), of chicken embryo fibroblasts ( CEF) infected by RSV mutants with a ts mutation of the src gene.	Chicken,0,7,Organism	embryo fibroblasts,8,26,Cell	hamster BHK cells,31,48,Cell	Rous sarcoma virus,64,82,Organism	RSV,85,88,Organism	chicken,273,280,Organism	embryo fibroblasts,281,299,Cell	CEF,302,305,Cell	RSV,319,322,Organism	src,357,360,Gene_or_gene_product	"[{""token"": ""Chicken"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 8, ""end_span"": 26, ""type"": ""Cell""}, {""token"": ""hamster BHK cells"", ""start_span"": 31, ""end_span"": 48, ""type"": ""Cell""}, {""token"": ""Rous sarcoma virus"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""RSV"", ""start_span"": 85, ""end_span"": 88, ""type"": ""Organism""}, {""token"": ""chicken"", ""start_span"": 273, ""end_span"": 280, ""type"": ""Organism""}, {""token"": ""embryo fibroblasts"", ""start_span"": 281, ""end_span"": 299, ""type"": ""Cell""}, {""token"": ""CEF"", ""start_span"": 302, ""end_span"": 305, ""type"": ""Cell""}, {""token"": ""RSV"", ""start_span"": 319, ""end_span"": 322, ""type"": ""Organism""}, {""token"": ""src"", ""start_span"": 357, ""end_span"": 360, ""type"": ""Gene_or_gene_product""}]"	train
Furthermore, rat mammary carcinomas with elevated neu expression ( neu - induced) also had sharply elevated LAR - PTPase expression when compared to rat mammary carcinomas with little or no neu expression ( 7, 12 - dimethylbenzanthracene induced); the level of expression of LAR PTPase was directly correlated with the level of neu expression.	rat,13,16,Organism	mammary carcinomas,17,35,Cancer	neu,50,53,Gene_or_gene_product	neu,67,70,Gene_or_gene_product	LAR - PTPase,108,120,Gene_or_gene_product	rat,149,152,Organism	mammary carcinomas,153,171,Cancer	neu,190,193,Gene_or_gene_product	LAR PTPase,275,285,Gene_or_gene_product	neu,328,331,Gene_or_gene_product	"[{""token"": ""rat"", ""start_span"": 13, ""end_span"": 16, ""type"": ""Organism""}, {""token"": ""mammary carcinomas"", ""start_span"": 17, ""end_span"": 35, ""type"": ""Cancer""}, {""token"": ""neu"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 67, ""end_span"": 70, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR - PTPase"", ""start_span"": 108, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 149, ""end_span"": 152, ""type"": ""Organism""}, {""token"": ""mammary carcinomas"", ""start_span"": 153, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""neu"", ""start_span"": 190, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""LAR PTPase"", ""start_span"": 275, ""end_span"": 285, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene_or_gene_product""}]"	train
Because thrombin cleavage of OPN results in substantial enhancement of OPN ' s adhesive properties, and because VPF / VEGF promotes increased microvascular permeability leading to activation of the extrinsic coagulation pathway, we also investigated whether VPF / VEGF facilitates thrombin cleavage of OPN in vivo.	thrombin,8,16,Gene_or_gene_product	OPN,29,32,Gene_or_gene_product	OPN,71,74,Gene_or_gene_product	VPF,112,115,Gene_or_gene_product	VEGF,118,122,Gene_or_gene_product	microvascular,142,155,Tissue	VPF,258,261,Gene_or_gene_product	VEGF,264,268,Gene_or_gene_product	thrombin,281,289,Gene_or_gene_product	OPN,302,305,Gene_or_gene_product	"[{""token"": ""thrombin"", ""start_span"": 8, ""end_span"": 16, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 29, ""end_span"": 32, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene_or_gene_product""}, {""token"": ""VPF"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 118, ""end_span"": 122, ""type"": ""Gene_or_gene_product""}, {""token"": ""microvascular"", ""start_span"": 142, ""end_span"": 155, ""type"": ""Tissue""}, {""token"": ""VPF"", ""start_span"": 258, ""end_span"": 261, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF"", ""start_span"": 264, ""end_span"": 268, ""type"": ""Gene_or_gene_product""}, {""token"": ""thrombin"", ""start_span"": 281, ""end_span"": 289, ""type"": ""Gene_or_gene_product""}, {""token"": ""OPN"", ""start_span"": 302, ""end_span"": 305, ""type"": ""Gene_or_gene_product""}]"	train
Compared with control animals transfected with LacZ, site - specific transfection of phVEGF resulted in augmented collateral vessel development documented by serial angiography, and improvement in calf blood pressure ratio ( ischemic to normal limb), resting and maximum blood flow, and capillary to myocyte ratio.	LacZ,47,51,Gene_or_gene_product	phVEGF,85,91,Gene_or_gene_product	collateral vessel,114,131,Multi	calf,197,201,Organism_subdivision	blood,202,207,Organism_substance	ischemic,225,233,Organism_subdivision	normal limb,237,248,Organism_subdivision	blood,271,276,Organism_substance	capillary,287,296,Tissue	myocyte,300,307,Cell	"[{""token"": ""LacZ"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene_or_gene_product""}, {""token"": ""phVEGF"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Gene_or_gene_product""}, {""token"": ""collateral vessel"", ""start_span"": 114, ""end_span"": 131, ""type"": ""Multi""}, {""token"": ""calf"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Organism_subdivision""}, {""token"": ""blood"", ""start_span"": 202, ""end_span"": 207, ""type"": ""Organism_substance""}, {""token"": ""ischemic"", ""start_span"": 225, ""end_span"": 233, ""type"": ""Organism_subdivision""}, {""token"": ""normal limb"", ""start_span"": 237, ""end_span"": 248, ""type"": ""Organism_subdivision""}, {""token"": ""blood"", ""start_span"": 271, ""end_span"": 276, ""type"": ""Organism_substance""}, {""token"": ""capillary"", ""start_span"": 287, ""end_span"": 296, ""type"": ""Tissue""}, {""token"": ""myocyte"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Cell""}]"	train
Because the identity of pulmonary endothelial SOCs is unknown, but mammalian homologues of the Drosophila melanogaster transient receptor potential ( trp) gene have been proposed to form Ca2 + entry channels in nonexcitable cells, we performed RT - PCR using Trp oligonucleotide primers in both rat and human pulmonary arterial endothelial cells.	endothelial,34,45,Cell	Drosophila melanogaster,95,118,Organism	transient receptor potential,119,147,Gene_or_gene_product	trp,150,153,Gene_or_gene_product	Ca2 +,187,192,Chemical	cells,224,229,Cell	Trp,259,262,Gene_or_gene_product	rat,295,298,Organism	human,303,308,Organism	pulmonary arterial endothelial cells,309,345,Cell	"[{""token"": ""endothelial"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""Drosophila melanogaster"", ""start_span"": 95, ""end_span"": 118, ""type"": ""Organism""}, {""token"": ""transient receptor potential"", ""start_span"": 119, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""trp"", ""start_span"": 150, ""end_span"": 153, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ca2 +"", ""start_span"": 187, ""end_span"": 192, ""type"": ""Chemical""}, {""token"": ""cells"", ""start_span"": 224, ""end_span"": 229, ""type"": ""Cell""}, {""token"": ""Trp"", ""start_span"": 259, ""end_span"": 262, ""type"": ""Gene_or_gene_product""}, {""token"": ""rat"", ""start_span"": 295, ""end_span"": 298, ""type"": ""Organism""}, {""token"": ""human"", ""start_span"": 303, ""end_span"": 308, ""type"": ""Organism""}, {""token"": ""pulmonary arterial endothelial cells"", ""start_span"": 309, ""end_span"": 345, ""type"": ""Cell""}]"	train
We have modelled multiple stages of malignant transformation of human endothelial cells ( ECs) by overexpressing the catalytic subunit of human telomerase ( hTERT), together with SV40 T antigen ( SV40T) and oncogenic N - ras.	human,64,69,Organism	endothelial cells,70,87,Cell	ECs,90,93,Cell	human,138,143,Organism	telomerase,144,154,Gene_or_gene_product	hTERT,157,162,Gene_or_gene_product	SV40,179,183,Organism	T antigen,184,193,Gene_or_gene_product	SV40T,196,201,Gene_or_gene_product	N - ras,217,224,Gene_or_gene_product	"[{""token"": ""human"", ""start_span"": 64, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""endothelial cells"", ""start_span"": 70, ""end_span"": 87, ""type"": ""Cell""}, {""token"": ""ECs"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 138, ""end_span"": 143, ""type"": ""Organism""}, {""token"": ""telomerase"", ""start_span"": 144, ""end_span"": 154, ""type"": ""Gene_or_gene_product""}, {""token"": ""hTERT"", ""start_span"": 157, ""end_span"": 162, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Organism""}, {""token"": ""T antigen"", ""start_span"": 184, ""end_span"": 193, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40T"", ""start_span"": 196, ""end_span"": 201, ""type"": ""Gene_or_gene_product""}, {""token"": ""N - ras"", ""start_span"": 217, ""end_span"": 224, ""type"": ""Gene_or_gene_product""}]"	valid
We defined the role of c - Myc in cancer cell sensitivity to vinblastine ( VLB) using human colon cancer cells: LoVo wild - type or transfected with a plasmid containing the human c - myc gene in antisense orientation ( LoVo - mycANS).	c - Myc,23,30,Gene_or_gene_product	cancer cell,34,45,Cell	vinblastine,61,72,Chemical	VLB,75,78,Chemical	human,86,91,Organism	colon cancer cells,92,110,Cell	LoVo,112,116,Cell	human,174,179,Organism	c - myc,180,187,Gene_or_gene_product	LoVo - mycANS,220,233,Cell	"[{""token"": ""c - Myc"", ""start_span"": 23, ""end_span"": 30, ""type"": ""Gene_or_gene_product""}, {""token"": ""cancer cell"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Cell""}, {""token"": ""vinblastine"", ""start_span"": 61, ""end_span"": 72, ""type"": ""Chemical""}, {""token"": ""VLB"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Chemical""}, {""token"": ""human"", ""start_span"": 86, ""end_span"": 91, ""type"": ""Organism""}, {""token"": ""colon cancer cells"", ""start_span"": 92, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""LoVo"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Cell""}, {""token"": ""human"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Organism""}, {""token"": ""c - myc"", ""start_span"": 180, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}, {""token"": ""LoVo - mycANS"", ""start_span"": 220, ""end_span"": 233, ""type"": ""Cell""}]"	valid
These results show that magnolol initiates apoptosis via the cytochrome - c / caspase 3 / PARP / AIF and PTEN / Akt / caspase 9 / PARP pathways and necrosis via PARP activation.	magnolol,24,32,Chemical	cytochrome - c,61,75,Gene_or_gene_product	caspase 3,78,87,Gene_or_gene_product	PARP,90,94,Gene_or_gene_product	AIF,97,100,Gene_or_gene_product	PTEN,105,109,Gene_or_gene_product	Akt,112,115,Gene_or_gene_product	caspase 9,118,127,Gene_or_gene_product	PARP,130,134,Gene_or_gene_product	PARP,161,165,Gene_or_gene_product	"[{""token"": ""magnolol"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Chemical""}, {""token"": ""cytochrome - c"", ""start_span"": 61, ""end_span"": 75, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 3"", ""start_span"": 78, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene_or_gene_product""}, {""token"": ""AIF"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 105, ""end_span"": 109, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 112, ""end_span"": 115, ""type"": ""Gene_or_gene_product""}, {""token"": ""caspase 9"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""PARP"", ""start_span"": 161, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}]"	valid
Furthermore, IL - 1beta - induced p38 mitogen - activated protein kinase ( MAPK) activation and upregulation of VEGF - C mRNA and protein in LLC cells was also suppressed by artemisinin or by the p38 MAPK inhibitor SB - 203580, suggesting that p38 MAPK could serve as a mediator of proinflammatory cytokine - induced VEGF - C expression.	IL - 1beta,13,23,Gene_or_gene_product	p38 mitogen - activated protein kinase,34,72,Gene_or_gene_product	MAPK,75,79,Gene_or_gene_product	VEGF - C,112,120,Gene_or_gene_product	LLC cells,141,150,Cell	artemisinin,174,185,Chemical	p38 MAPK,196,204,Gene_or_gene_product	SB - 203580,215,226,Chemical	p38 MAPK,244,252,Gene_or_gene_product	VEGF - C,317,325,Gene_or_gene_product	"[{""token"": ""IL - 1beta"", ""start_span"": 13, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""p38 mitogen - activated protein kinase"", ""start_span"": 34, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 75, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 112, ""end_span"": 120, ""type"": ""Gene_or_gene_product""}, {""token"": ""LLC cells"", ""start_span"": 141, ""end_span"": 150, ""type"": ""Cell""}, {""token"": ""artemisinin"", ""start_span"": 174, ""end_span"": 185, ""type"": ""Chemical""}, {""token"": ""p38 MAPK"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Gene_or_gene_product""}, {""token"": ""SB - 203580"", ""start_span"": 215, ""end_span"": 226, ""type"": ""Chemical""}, {""token"": ""p38 MAPK"", ""start_span"": 244, ""end_span"": 252, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGF - C"", ""start_span"": 317, ""end_span"": 325, ""type"": ""Gene_or_gene_product""}]"	valid
To characterize the effects of CK1delta on SV40 - induced mammary carcinogenesis, we generated transgenic mice expressing mutant CK1delta under the control of the whey acidic protein ( WAP) gene promoter, and crossed them with SV40 transgenic WAP - T - antigen ( WAP - T) mice.	CK1delta,31,39,Gene_or_gene_product	SV40,43,47,Organism	mammary,58,65,Organ	transgenic mice,95,110,Organism	CK1delta,129,137,Gene_or_gene_product	whey acidic protein,163,182,Gene_or_gene_product	WAP,185,188,Gene_or_gene_product	SV40,227,231,Organism	WAP - T - antigen,243,260,Gene_or_gene_product	WAP - T,263,270,Gene_or_gene_product	"[{""token"": ""CK1delta"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Organism""}, {""token"": ""mammary"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Organ""}, {""token"": ""transgenic mice"", ""start_span"": 95, ""end_span"": 110, ""type"": ""Organism""}, {""token"": ""CK1delta"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Gene_or_gene_product""}, {""token"": ""whey acidic protein"", ""start_span"": 163, ""end_span"": 182, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP"", ""start_span"": 185, ""end_span"": 188, ""type"": ""Gene_or_gene_product""}, {""token"": ""SV40"", ""start_span"": 227, ""end_span"": 231, ""type"": ""Organism""}, {""token"": ""WAP - T - antigen"", ""start_span"": 243, ""end_span"": 260, ""type"": ""Gene_or_gene_product""}, {""token"": ""WAP - T"", ""start_span"": 263, ""end_span"": 270, ""type"": ""Gene_or_gene_product""}]"	valid
The detection of increased abundance of EGF - R or Her - 2 / neu proteins in human tumours can provide additional information on the disease - free survival and overall survival for patients with breast, ovarian, endometrial or cervical cancer.	EGF - R,40,47,Gene_or_gene_product	Her - 2,51,58,Gene_or_gene_product	neu,61,64,Gene_or_gene_product	human,77,82,Organism	tumours,83,90,Cancer	patients,182,190,Organism	breast,196,202,Cancer	ovarian,204,211,Cancer	endometrial,213,224,Cancer	cervical cancer,228,243,Cancer	"[{""token"": ""EGF - R"", ""start_span"": 40, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""Her - 2"", ""start_span"": 51, ""end_span"": 58, ""type"": ""Gene_or_gene_product""}, {""token"": ""neu"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 77, ""end_span"": 82, ""type"": ""Organism""}, {""token"": ""tumours"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Cancer""}, {""token"": ""patients"", ""start_span"": 182, ""end_span"": 190, ""type"": ""Organism""}, {""token"": ""breast"", ""start_span"": 196, ""end_span"": 202, ""type"": ""Cancer""}, {""token"": ""ovarian"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Cancer""}, {""token"": ""endometrial"", ""start_span"": 213, ""end_span"": 224, ""type"": ""Cancer""}, {""token"": ""cervical cancer"", ""start_span"": 228, ""end_span"": 243, ""type"": ""Cancer""}]"	valid
Since other DNA tumor viruses, such as simian virus 40 and adenovirus, have previously been shown to interact with cellular protein p53, we investigated whether infection of cells by HCMV would modulate cellular p53 levels.	DNA,12,15,Cellular_component	tumor,16,21,Cancer	simian virus 40,39,54,Organism	adenovirus,59,69,Organism	cellular,115,123,Cell	p53,132,135,Gene_or_gene_product	cells,174,179,Cell	HCMV,183,187,Organism	cellular,203,211,Cell	p53,212,215,Gene_or_gene_product	"[{""token"": ""DNA"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Cellular_component""}, {""token"": ""tumor"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Cancer""}, {""token"": ""simian virus 40"", ""start_span"": 39, ""end_span"": 54, ""type"": ""Organism""}, {""token"": ""adenovirus"", ""start_span"": 59, ""end_span"": 69, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene_or_gene_product""}, {""token"": ""cells"", ""start_span"": 174, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""HCMV"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Organism""}, {""token"": ""cellular"", ""start_span"": 203, ""end_span"": 211, ""type"": ""Cell""}, {""token"": ""p53"", ""start_span"": 212, ""end_span"": 215, ""type"": ""Gene_or_gene_product""}]"	valid
HCMV immediate - early proteins were clearly shown to be responsible for elevating p53 levels in infected fibroblasts; expression of HCMV immediate - early region 1 and 2 proteins resulted in elevation of p53 levels in transfected human fibroblasts.	HCMV,0,4,Organism	immediate - early proteins,5,31,Gene_or_gene_product	p53,83,86,Gene_or_gene_product	fibroblasts,106,117,Cell	HCMV,133,137,Organism	immediate - early region 1,138,164,Gene_or_gene_product	2,169,170,Gene_or_gene_product	p53,205,208,Gene_or_gene_product	human,231,236,Organism	fibroblasts,237,248,Cell	"[{""token"": ""HCMV"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Organism""}, {""token"": ""immediate - early proteins"", ""start_span"": 5, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""fibroblasts"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Cell""}, {""token"": ""HCMV"", ""start_span"": 133, ""end_span"": 137, ""type"": ""Organism""}, {""token"": ""immediate - early region 1"", ""start_span"": 138, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""2"", ""start_span"": 169, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 205, ""end_span"": 208, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 231, ""end_span"": 236, ""type"": ""Organism""}, {""token"": ""fibroblasts"", ""start_span"": 237, ""end_span"": 248, ""type"": ""Cell""}]"	valid
Co - expression of NRP1 and ( VEGFR - 2) KDR on the surface of endothelial cells ( EC) enhances VEGF165 binding to KDR and EC chemotaxis in response to VEGF165.	NRP1,19,23,Gene_or_gene_product	VEGFR - 2,30,39,Gene_or_gene_product	KDR,41,44,Gene_or_gene_product	surface,52,59,Cellular_component	endothelial cells,63,80,Cell	EC,83,85,Cell	VEGF165,96,103,Gene_or_gene_product	KDR,115,118,Gene_or_gene_product	EC,123,125,Cell	VEGF165,152,159,Gene_or_gene_product	"[{""token"": ""NRP1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""surface"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"	test
Following cotransfection of p53 - null EU - 4 cells with survivin promoter - luciferase constructs and either wt - p53 or different mut - p53 expression vectors, wt - p53 inhibited survivin promoter activity; p53 - mediated inhibition could be abrogated by overexpression of murine double minute2 ( MDM2) protein.	p53,28,31,Gene_or_gene_product	survivin,57,65,Gene_or_gene_product	luciferase,77,87,Gene_or_gene_product	p53,115,118,Gene_or_gene_product	p53,138,141,Gene_or_gene_product	p53,167,170,Gene_or_gene_product	survivin,181,189,Gene_or_gene_product	p53,209,212,Gene_or_gene_product	murine double minute2,275,296,Gene_or_gene_product	MDM2,299,303,Gene_or_gene_product	"[{""token"": ""p53"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine double minute2"", ""start_span"": 275, ""end_span"": 296, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 299, ""end_span"": 303, ""type"": ""Gene_or_gene_product""}]"	test
To assess its role on human vascular lung development, we first examined the expression of IGF - I / II and IGF receptor type I ( IGF - IR) in human embryonic and fetal lung tissues at 4 - 12 wk of gestation.	human,22,27,Organism	vascular,28,36,Multi	lung,37,41,Organ	IGF - I,91,98,Gene_or_gene_product	II,101,103,Gene_or_gene_product	IGF receptor type I,108,127,Gene_or_gene_product	IGF - IR,130,138,Gene_or_gene_product	human,143,148,Organism	embryonic,149,158,Tissue	fetal lung tissues,163,181,Tissue	"[{""token"": ""human"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""vascular"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Organ""}, {""token"": ""IGF - I"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF receptor type I"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""embryonic"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Tissue""}, {""token"": ""fetal lung tissues"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Tissue""}]"	test
For this purpose, the presence of COX - 2 and PPARgamma was immunohistochemically examined in 71 epithelial ovarian carcinomas, 18 borderline tumours and 23 benign tumours and the levels of COX - 2 and PPARgamma proteins were determined by enzyme immunoassay in four benign tumours, three borderline tumours and 12 carcinomas.	COX - 2,34,41,Gene_or_gene_product	PPARgamma,46,55,Gene_or_gene_product	epithelial ovarian carcinomas,97,126,Cancer	tumours,142,149,Cancer	tumours,164,171,Cancer	COX - 2,190,197,Gene_or_gene_product	PPARgamma,202,211,Gene_or_gene_product	tumours,274,281,Cancer	tumours,300,307,Cancer	carcinomas,315,325,Cancer	"[{""token"": ""COX - 2"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial ovarian carcinomas"", ""start_span"": 97, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""COX - 2"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Cancer""}, {""token"": ""carcinomas"", ""start_span"": 315, ""end_span"": 325, ""type"": ""Cancer""}]"	test
Here, we discuss the possibility for MMPs to contribute to pericyte recruitment at six levels: ( 1) direct promotion of pericyte invasion by extracellular matrix degradation; ( 2) stimulation of pericyte proliferation and protection against apoptosis by modification of the ECM; ( 3) activation of pericytes through the release of growth factor bound to the ECM; ( 4) transactivation of angiogenic cell surface receptor; ( 5) propagation of angiogenic signalling as cofactor; and ( 6) recruitment of bone marrow - derived stem cells.	MMPs,37,41,Gene_or_gene_product	pericyte,59,67,Cell	pericyte,120,128,Cell	extracellular matrix,141,161,Cellular_component	pericyte,195,203,Cell	ECM,274,277,Cellular_component	pericytes,298,307,Cell	ECM,358,361,Cellular_component	cell surface,398,410,Cellular_component	bone marrow - derived stem cells,500,532,Cell	"[{""token"": ""MMPs"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""pericyte"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 141, ""end_span"": 161, ""type"": ""Cellular_component""}, {""token"": ""pericyte"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Cell""}, {""token"": ""ECM"", ""start_span"": 274, ""end_span"": 277, ""type"": ""Cellular_component""}, {""token"": ""pericytes"", ""start_span"": 298, ""end_span"": 307, ""type"": ""Cell""}, {""token"": ""ECM"", ""start_span"": 358, ""end_span"": 361, ""type"": ""Cellular_component""}, {""token"": ""cell surface"", ""start_span"": 398, ""end_span"": 410, ""type"": ""Cellular_component""}, {""token"": ""bone marrow - derived stem cells"", ""start_span"": 500, ""end_span"": 532, ""type"": ""Cell""}]"	test
In fact, p75 ( NTR) depresses the VEGF - A / Akt / eNOS / NO pathway and additionally reduces the mRNA levels of ITGB1 [ beta ( 1) integrin], BIRC5 ( survivin), PTTG1 ( securin) and VEZF1.	VEGF - A,34,42,Gene_or_gene_product	Akt,45,48,Gene_or_gene_product	eNOS,51,55,Gene_or_gene_product	NO,58,60,Chemical	ITGB1,113,118,Gene_or_gene_product	BIRC5,142,147,Gene_or_gene_product	survivin,150,158,Gene_or_gene_product	PTTG1,161,166,Gene_or_gene_product	securin,169,176,Gene_or_gene_product	VEZF1,182,187,Gene_or_gene_product	"[{""token"": ""VEGF - A"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""eNOS"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""NO"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""ITGB1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTTG1"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""securin"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEZF1"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"	test
Western blotting analysis showed that liposomal honokiol - inhibited Akt and MAPK phosphorylation in 2 endothelial cells, and downregulated expressions of VEGFR - 2 of human vascular endothelial cells and VEGFR - 3 of lymphatic endothelial cells.	liposomal,38,47,Cellular_component	honokiol,48,56,Chemical	Akt,69,72,Gene_or_gene_product	MAPK,77,81,Gene_or_gene_product	endothelial cells,103,120,Cell	VEGFR - 2,155,164,Gene_or_gene_product	human,168,173,Organism	vascular endothelial cells,174,200,Cell	VEGFR - 3,205,214,Gene_or_gene_product	lymphatic endothelial cells,218,245,Cell	"[{""token"": ""liposomal"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Cellular_component""}, {""token"": ""honokiol"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 103, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""VEGFR - 2"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Organism""}, {""token"": ""vascular endothelial cells"", ""start_span"": 174, ""end_span"": 200, ""type"": ""Cell""}, {""token"": ""VEGFR - 3"", ""start_span"": 205, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphatic endothelial cells"", ""start_span"": 218, ""end_span"": 245, ""type"": ""Cell""}]"	test
Rather, it has been hypothesized that, at low concentrations, MBDs produce more subtle effects on microtubule dynamics, block critical cell signaling pathways, and prevent the microtubules from properly interacting with transient subcellular assemblies ( focal adhesions and adherens junctions) whose subsequent stabilization and / or maturation are required for cell motility and cell - cell interactions.	MBDs,62,66,Chemical	microtubule,98,109,Cellular_component	cell,135,139,Cell	microtubules,176,188,Cellular_component	subcellular assemblies,230,252,Cellular_component	focal adhesions,255,270,Cellular_component	adherens junctions,275,293,Cellular_component	cell,363,367,Cell	cell,381,385,Cell	cell,388,392,Cell	"[{""token"": ""MBDs"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""microtubule"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""microtubules"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Cellular_component""}, {""token"": ""subcellular assemblies"", ""start_span"": 230, ""end_span"": 252, ""type"": ""Cellular_component""}, {""token"": ""focal adhesions"", ""start_span"": 255, ""end_span"": 270, ""type"": ""Cellular_component""}, {""token"": ""adherens junctions"", ""start_span"": 275, ""end_span"": 293, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 363, ""end_span"": 367, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 381, ""end_span"": 385, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 388, ""end_span"": 392, ""type"": ""Cell""}]"	test
TSC2 and PTEN are two key inhibitors of the Akt / mammalian target of rapamycin ( mTOR) pathway and the specific inhibition of mTOR with rapamycin or RAD001 inhibited cell proliferation of PET cell lines.	TSC2,0,4,Gene_or_gene_product	PTEN,9,13,Gene_or_gene_product	Akt,44,47,Gene_or_gene_product	mammalian target of rapamycin,50,79,Gene_or_gene_product	mTOR,82,86,Gene_or_gene_product	mTOR,127,131,Gene_or_gene_product	rapamycin,137,146,Chemical	RAD001,150,156,Chemical	cell,167,171,Cell	PET cell lines,189,203,Cell	"[{""token"": ""TSC2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammalian target of rapamycin"", ""start_span"": 50, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""rapamycin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Chemical""}, {""token"": ""RAD001"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""PET cell lines"", ""start_span"": 189, ""end_span"": 203, ""type"": ""Cell""}]"	test
Ectopic expression of TLX in the U87MG glioma cell line and Ink4a / Arf - deficient mouse astrocytes ( Ink4a / Arf ( - / -) astrocytes) induced cell proliferation with a concomitant increase in cyclin D expression, and accelerated foci formation in soft agar and tumor formation in in vivo transplantation assays.	TLX,22,25,Gene_or_gene_product	U87MG glioma cell line,33,55,Cell	Ink4a,60,65,Gene_or_gene_product	Arf,68,71,Gene_or_gene_product	Ink4a,103,108,Gene_or_gene_product	Arf,111,114,Gene_or_gene_product	cell,144,148,Cell	cyclin D,194,202,Gene_or_gene_product	foci,231,235,Cell	tumor,263,268,Cancer	"[{""token"": ""TLX"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""U87MG glioma cell line"", ""start_span"": 33, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""Ink4a"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cyclin D"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""foci"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Cancer""}]"	test
The apparent mesenchymal to epithelial conversion of the tumor cells mimics the conversion that occurs during embryonic kidney development, suggesting that Met - HGF / SF signaling plays a role in this process as well as in tumors that express both epithelial and mesenchymal markers.	mesenchymal,13,24,Cell	epithelial,28,38,Cell	tumor cells,57,68,Cell	embryonic kidney,110,126,Organ	Met,156,159,Gene_or_gene_product	HGF,162,165,Gene_or_gene_product	SF,168,170,Gene_or_gene_product	tumors,224,230,Cancer	epithelial,249,259,Cell	mesenchymal,264,275,Cell	"[{""token"": ""mesenchymal"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""embryonic kidney"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""Met"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 168, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""epithelial"", ""start_span"": 249, ""end_span"": 259, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 264, ""end_span"": 275, ""type"": ""Cell""}]"	test
Murine leukemia L1210 cells rendered deficient in glutathione peroxidase ( GPX) and phospholipid hydroperoxide glutathione peroxidase ( PHGPX) by Se deprivation ( L. Se ( -) cells) were found to be more sensitive to tert - butyl hydroperoxide ( t - BuOOH) cytotoxicity than Se - replete controls ( L. Se ( +) cells).	Murine,0,6,Organism	leukemia L1210 cells,7,27,Cell	glutathione peroxidase,50,72,Gene_or_gene_product	GPX,75,78,Gene_or_gene_product	phospholipid hydroperoxide glutathione peroxidase,84,133,Gene_or_gene_product	PHGPX,136,141,Gene_or_gene_product	Se,146,148,Chemical	tert - butyl hydroperoxide,216,242,Chemical	t - BuOOH,245,254,Chemical	Se,274,276,Chemical	"[{""token"": ""Murine"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism""}, {""token"": ""leukemia L1210 cells"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""glutathione peroxidase"", ""start_span"": 50, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""GPX"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipid hydroperoxide glutathione peroxidase"", ""start_span"": 84, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""PHGPX"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Se"", ""start_span"": 146, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""tert - butyl hydroperoxide"", ""start_span"": 216, ""end_span"": 242, ""type"": ""Chemical""}, {""token"": ""t - BuOOH"", ""start_span"": 245, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""Se"", ""start_span"": 274, ""end_span"": 276, ""type"": ""Chemical""}]"	test
Many cellular and biochemical effects of curcumin in mouse fibroblast cells have been reported, such as inhibition of protein kinase C ( PKC) activity induced by phorbol 12 - myristate 13 - acetate treatment, inhibition of tyrosine protein kinase activity, and inhibition of arachidonic acid ( AA) metabolism.	cellular,5,13,Cell	curcumin,41,49,Chemical	mouse,53,58,Organism	fibroblast cells,59,75,Cell	protein kinase C,118,134,Gene_or_gene_product	PKC,137,140,Gene_or_gene_product	phorbol 12 - myristate 13 - acetate,162,197,Chemical	tyrosine,223,231,Amino_acid	arachidonic acid,275,291,Chemical	AA,294,296,Chemical	"[{""token"": ""cellular"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""curcumin"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""fibroblast cells"", ""start_span"": 59, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKC"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol 12 - myristate 13 - acetate"", ""start_span"": 162, ""end_span"": 197, ""type"": ""Chemical""}, {""token"": ""tyrosine"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Amino_acid""}, {""token"": ""arachidonic acid"", ""start_span"": 275, ""end_span"": 291, ""type"": ""Chemical""}, {""token"": ""AA"", ""start_span"": 294, ""end_span"": 296, ""type"": ""Chemical""}]"	test
